List of Software Companies in United Kingdom - 16

Autoscribe offers a wide portfolio of Laboratory Information Management Systems (LIMS). We develop, implement and support configurable Solutions for customers in the USA, UK and worldwide in a variety of industries, such as: - Pharmaceuticals; Drug Discovery, Development & Manufacture - Healthcare & Medical Research - Biobanking - Veterinary - Petrochemicals - Food & Beverage - Energy & Power Utilities - Minerals & Mining - Building & Construction - Environmental Management - Telecommunications - Consumer Products - Contract Testing Laboratories Available on and off the shelf, our scalable, fully configurable LIMS, help our customers manage their laboratory workflow in a key areas such as, but not limited to: - Individual & Bulk sample Entry / Registration - Sample Reception, Preparation, & Allocation - Creation of Test suites - Test Scheduling - Result entry & Validation - Quality Control - Result Approval & Report Analysis Further benefits which add value to our solutions are: - Dynamic Reporting - Barcoding Capability - Competency Monitoring and Management - Resource Planning - Instrument Calibration and Maintenance - Instrument Data Importing - Complaints & Feedback Management - Regulatory Compliance for Audit - In-built Future Proofing - Concurrent, Perpetual Licences - Ability to link to multiple on or off-site Labs - Proof of Concept available - Localized Support for all International customers Autoscribe also regularly hosts free Seminars and Training Workshops. For more details, visit our official website below:

Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. We match and refine novel proteins for our partners' exact industrial, therapeutic or diagnostic applications using BaseGraph™, a new generation of AI design that is powered by the first-ever high-resolution map of global genetic biodiversity. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. We're a team of explorers, scientists and policy experts driven by our ambition to protect and learn from nature's diversity, whilst delivering life-changing breakthroughs to those who need them most.

BioCorteX is a biotechnology company that utilizes artificial intelligence and computational modeling to enhance therapeutic development, particularly in the area of microbiome-host interactions. The company operates through two entities: Biocortex Ltd, established in the UK in 2021, and BIOCORTEX, INC., which opened in 2023. BioCorteX specializes in AI-driven platforms that aim to reduce risks in drug development and improve clinical trial outcomes. The company offers several core services, including in silico clinical trials that simulate drug-bacteria-host interactions to predict clinical outcomes, microbiome analysis to assess how bacterial diversity affects drug efficacy, and therapeutic development support for various sectors such as pharmaceuticals and cosmetics. Their proprietary foundational emulator integrates microbiome data with AI to simulate human physiological responses to drugs, while their drug interaction models test numerous medications to identify success factors, particularly in antibody-drug conjugates for cancer therapy. BioCorteX targets pharmaceutical companies, biotech firms, and the cosmetics industry, providing insights to optimize product performance and safety.

We have 24 years of experience doing Process Simulation and Economic Analysis! Our software has 15 years of history now. You may know BioSolve Process, which can let you evaluate the following and beyond: - Process Optimization - Process Simulation - Techno-Economic Assessment - Green Design which can feed into LCA Our users can be: - MSAT - R&D Scientists - Managements to review the data - Tech Transfer - Innovative Supplier - Engineers Back in December 1998, Biopharm Services was founded by Andrew Sinclair to develop technology solutions and services for: - the biopharmaceutical manufacturing business - covering biologic products (inc. viral vectors, mRNA, ADC and more) - and facilities and manufacturing strategy

We turn ordinary scans into extraordinary insights because every patient deserves expert-level care, anywhere. Impactful. Scalable. Smart. Brainomix 360 enhances stroke imaging interpretation for neurologists, interventionalists, and radiologists while seamlessly fitting into existing radiology workflows. Delivering the right insights, to the right people, at the right time. Since our 2010 spin-out from the University of Oxford, we've developed award-winning, AI-powered imaging biomarkers and software solutions that empower physicians worldwide to make critical, life-saving decisions in stroke and lung care.

Cumulus Neuroscience is a global digital health company focused on advancing neuroscience clinical trials and research. They collaborate with leading global pharmaceutical companies to meet the industry's complex clinical trial needs. Cumulus Neuroscience offers a unique career and is known for its innovative assessment platform for identifying brain disorders.

EKF is a leading global diagnostics and biotechnology company specialising in the development, production, and distribution of leading medical technologies and patient-centric solutions. Our diagnostic technologies and biotechnology solutions empower healthcare professionals and non-medical practitioners to make informed decisions through point-of-care testing and life sciences applications. Point-of-Care: EKF develops and manufactures medical devices and tests (in-vitro diagnostics (IVD)) that can be used at or near the patient's location. Designed to provide quick and accurate results, these tests (and optional data connectivity software) enable healthcare professionals to make rapid decisions. Diabetes care: EKF offers a range of products related to diabetes care, including glucose monitoring systems and associated supplies and consumables. Hematology solutions: EKF provides products, supplies, and consumables for measuring hemoglobin levels, including those used for the detection of hemoglobin variants. Life Sciences: EKF develops and supplies diagnostic and therapeutic enzymes, proteins, reagents, and other bio-materials used in the research, biotechnology, and pharmaceutical industries. Dedicated to supporting clinicians, scientists and researchers these high-quality materials can be used in multiple applications. Enzyme Fermentation: EKF offers precision fermentation, custom bioprocessing and contract manufacturing services related to the production of pharmaceuticals and other biologics. Beta-hydroxybutyrate (β-HB): EKF provides β-HB products which are used to detect ketones, to help identify patients suffering from diabetic ketoacidosis, and other clinical applications. As a global leader in the development and distribution of diagnostic technologies and biotechnology solutions, EKF has a presence in over 120 countries with the solutions needed to support better health and wellness worldwide.

At Lifebit, we're pushing forward the frontiers of health and knowledge by democratising access to omics data. We enable all researchers, whether novice or advanced, to run complex analyses and generate meaningful insights fast. Lifebit CloudOS is the world’s first federated genomics platform for unified and secure research over distributed big data - wherever data resides. From top tier pharmaceutical organisations to global research institutes to genetics companies and more, Lifebit CloudOS leads the way with our best-in-class UX/UI, seamless integration to open-source tools, marketplace of proprietary ones, powerful cohort browser, and advanced AI functionality. At Lifebit, we are open source pioneers, innovators redefining our industry. Our driving mission - to revolutionise bioinformatics and biomedical data analysis forever. We are growing fast and looking for more superstars to join our team.

At Metofico, we specialise in developing no-code data analysis software tailored specifically for life science research. We are dedicated to making powerful tools accessible to all researchers—regardless of coding expertise. Our mission is to enhance the efficiency, reliability, and reproducibility of data analysis, empowering scientists to focus on advancing scientific discoveries instead of spending time on tedious data processing. Our suite of tools—ranging from Fiber photometry analysis to AI-driven rodent tracking and automated behaviour quantification—is designed to streamline preclinical research. Additionally, we provide custom software and hardware solutions tailored to the unique needs of each research project. We uphold the highest scientific standards and continuously refine our offerings based on valuable feedback from the research community.

At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system. Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. Optibrium’s lead product, StarDrop™, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. The company’s new Augmented Chemistry™ products and services deliver ground-breaking artificial intelligence technologies that continuously learn from all available data to supplement your experience and skills. Founded in 2009, Optibrium is headquartered in Cambridge, UK with offices in Boston and San Francisco, USA. Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of the drug discovery process. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotech and academic groups.

Rayner manufactured the world's first IOL in 1949, and has remained at the forefront of innovation for over 70 years, focused on providing you and your patients with the best IOLs and ophthalmic solutions - always driven by science to improve patient outcomes and safety. Rayner is the only manufacturer of IOLs in the UK, with its state-of-the-art manufacturing plant and Global Headquarters on the South Coast of England. Rayner is a fast-paced and growing business with 500+ employees worldwide.

Sonrai is the only multi-omic cloud AI solution designed for precision medicine. Our experts have developed a Bioinformatics Cloud product explicitly designed to work with precision medicine data, alleviate pain points, and help succeed from early discovery through to clinical phases and beyond.

Synthace is a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. It allows biologists to design, plan, and automate experiments in a single place, then automatically gather structured experiment data and metadata in a unified no-code environment.

Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure. Learn more: https://www.ultromics.com/. Follow Ultromics on social media for the latest news, X: https://x.com/ultromics, LinkedIn: https://www.linkedin.com/company/ultromics/.

Zetta provides large-scale genomic data management using distributed database technology and best practice security techniques to leverage genomicdata benefits while preserving data privacy.